IMU 1.41% 7.0¢ imugene limited

Red tape is strangling the bio-tech sector and its trials,...

  1. 12,026 Posts.
    lightbulb Created with Sketch. 3660
    Red tape is strangling the bio-tech sector and its trials, everything has to be " lawyer proof " and of course patient proof as well. PD1 got the FDA green light in February with expectations to start this month and despite the clear path it takes longer. Recruiting isn't that easy due to trial specification and local circumstances like currently HerVaxx recruiting delays in India.

    PTX expects to Ann's its breast cancer ph2 readings soon after 8 years since trial pH 1, B-Vaxx pH 1 started 2014 and just extended ph2, compared to that HerVaxx is a Ferrari and PD1-Vaxx might get it done even faster, maybe 3-4 years.

    It all takes time despite we think " Just give them the vaxx now, can't get worse than patient dying as expected anyway" if diagnosed with stage 4.

    GLTA

 
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
(20min delay)
Last
7.0¢
Change
-0.001(1.41%)
Mkt cap ! $512.3M
Open High Low Value Volume
7.2¢ 7.4¢ 7.0¢ $966.4K 13.61M

Buyers (Bids)

No. Vol. Price($)
6 279146 7.0¢
 

Sellers (Offers)

Price($) Vol. No.
7.1¢ 877993 20
View Market Depth
Last trade - 14.51pm 15/05/2024 (20 minute delay) ?
Last
7.0¢
  Change
-0.001 ( 2.64 %)
Open High Low Volume
7.2¢ 7.3¢ 7.0¢ 5807363
Last updated 15.12pm 15/05/2024 ?
IMU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.